Your browser doesn't support javascript.
loading
Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design.
Vernhes, Emeline; Larbi Chérif, Linda; Ducrot, Nicolas; Vanbergue, Clément; Ouldali, Malika; Zig, Lena; Sidibe, N'diaye; Hoos, Sylviane; Ramirez-Chamorro, Luis; Renouard, Madalena; Rossier, Ombeline; England, Patrick; Schoehn, Guy; Boulanger, Pascale; Benihoud, Karim.
Afiliación
  • Vernhes E; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.
  • Larbi Chérif L; Université Paris-Saclay, Gustave Roussy, CNRS, Metabolic and systemic aspects of oncogenesis for new therapeutic approaches (METSY), 94805, Villejuif, France.
  • Ducrot N; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.
  • Vanbergue C; Université Paris-Saclay, Gustave Roussy, CNRS, Metabolic and systemic aspects of oncogenesis for new therapeutic approaches (METSY), 94805, Villejuif, France.
  • Ouldali M; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.
  • Zig L; Université Paris-Saclay, Gustave Roussy, CNRS, Metabolic and systemic aspects of oncogenesis for new therapeutic approaches (METSY), 94805, Villejuif, France.
  • Sidibe N; Université Paris-Saclay, Gustave Roussy, CNRS, Metabolic and systemic aspects of oncogenesis for new therapeutic approaches (METSY), 94805, Villejuif, France.
  • Hoos S; Institut Pasteur, Biophysique Moléculaire, CNRS UMR 3528, Paris, France.
  • Ramirez-Chamorro L; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.
  • Renouard M; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.
  • Rossier O; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.
  • England P; Institut Pasteur, Biophysique Moléculaire, CNRS UMR 3528, Paris, France.
  • Schoehn G; Univ. Grenoble Alpes, CNRS, CEA, IBS, F-38000, Grenoble, France.
  • Boulanger P; Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France. pascale.boulanger@i2bc.paris-saclay.fr.
  • Benihoud K; Université Paris-Saclay, Gustave Roussy, CNRS, Metabolic and systemic aspects of oncogenesis for new therapeutic approaches (METSY), 94805, Villejuif, France. karim.benihoud@gustaveroussy.fr.
NPJ Vaccines ; 9(1): 6, 2024 Jan 04.
Article en En | MEDLINE | ID: mdl-38177231
ABSTRACT
The promises of vaccines based on virus-like particles stimulate demand for universal non-infectious virus-like platforms that can be efficiently grafted with large antigens. Here, we harnessed the modularity and extreme affinity of the decoration protein pb10 for the capsid of bacteriophage T5. SPR experiments demonstrated that pb10 fused to mCherry or to the model antigen ovalbumin (Ova) retained picomolar affinity for DNA-free T5 capsid-like particles (T5-CLPs), while cryo-EM studies attested to the full occupancy of the 120 capsid binding sites. Mice immunization with CLP-bound pb10-Ova chimeras elicited strong long-lasting anti-Ova humoral responses involving a large panel of isotypes, as well as CD8+ T cell responses, without any extrinsic adjuvant. Therefore, T5-CLP constitutes a unique DNA-free bacteriophage capsid able to display a regular array of large antigens through highly efficient chemical-free anchoring. Its ability to elicit robust immune responses paves the way for further development of this novel vaccination platform.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2024 Tipo del documento: Article País de afiliación: Francia
...